who we are

STEMAXON has been nominated as a finalist for the ADRIQ's ''26th INNOVATION AWARD''

MEMBER OF BIOQUÉBEC

Stem Cells: Regeneration Methods for the Visual System

La biología y el tratamiento de la ceguera con células madre

​​The Biology of Treating Blindness with Stem Cells

El trasplante de fotorreceptores llega para curar la degeneración macular

STEMAXON is a Canadian biotechnology company located in the Greater Montréal Area which specializes in stem cell technology.

Des cellulles souches pour soigner la vision

STEMAXON to validate the technology of iPSC differentiation into photoreceptor cells for cell therapy applications

Restoring vision with stem cells

Intellectual property

STEMAXON​'s cumulative IP, starting with the only proven human sporadic AD model (PCT) and AD-cascade related compounds (PCT) greatly advance drug development and testing in the treatment and early stage diagnostics of Alzheimer’ disease.



STEMAXON's Legal partners are Fasken Martineau.



Stem Cell Advance Brings Vision Repair in Sight

​​FOLLOW US ON LINKEDIN

ADVANCED RESEARCH FOR LIFE

In the News:

FOR ALL THE LATEST NEWS, PLEASE VISIT OUR LINKEDIN PAGE